Faculty of Medicine

Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14

Browse

Settings

Author: search.filters.author.Baloski, MarjanSubject: search.filters.subject.pulmonary embolism

Search Results

Now showing 1 - 3 of 3
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Special Conditions in Venous Thrombembolism - Case Series
    (Macedonian Academy of Sciences and Arts/Walter de Gruyter GmbH, 2019-10-01)
    ;
    ;
    ;
    Klincheva, Milka
    ;
    Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent vascular diseases. There is a lack of knowledge with regards to contemporary presentation, management, and outcomes of patients with VTE. Many clinically important subgroups (including the elderly, those with recent bleeding, renal insufficiency, disseminated malignancy or pregnant patients) have been under-represented in randomized clinical trials. We still need information from real life data (as example RIETE). The paper presents case series with VTE in special conditions, including cancer associated thrombosis, malignant homeopathies, as well in high risk population.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Special Conditions in Venous Thrombembolism – Case Series
    (Macedonian Academy of Sciences and Arts, 2019-10-01)
    ;
    ;
    ;
    Klincheva, Milka
    ;
    Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent vascular diseases. There is a lack of knowledge with regards to contemporary presentation, management, and outcomes of patients with VTE. Many clinically important subgroups (including the elderly, those with recent bleeding, renal insufficiency, disseminated malignancy or pregnant patients) have been under-represented in randomized clinical trials. We still need information from real life data (as example RIETE). The paper presents case series with VTE in special conditions, including cancer associated thrombosis, malignant homeopathies, as well in high risk population.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    DEEP VEIN THROMBOSIS AND RECURENT PULMONARY EMBOLISM IN A PATIENT WITH THROMBOPHILIC MUTATIONS AND GENERALIZED PSORIASIS: A CASE REPORT
    (Association of medical doctors "Sanamed" Novi Pazar, 2020-07-29)
    Baloski, Marjan
    ;
    ;
    Brishkoska Boshkovski, Vesna
    ;
    Hasan, Taner
    ;
    Nedeska Minova, Natasha
    Introduction: Genetic risk factors that increase venous thromboembolism risk are disorders in the synthesis or activity of coagulation factors. Fac- tor V Leiden, prothrombin (20210-A), antithrombin deficiency, protein C and protein S deficiency, and hyperhomocysteinaemia are the most common venous thromboembolism-related gene mutations. When ge- netic factors are combined with non-provoking risk factors (obesity, psoriasis, smoking and previous veno- us thromboembolism) the result is increased venous thromboembolism risk for each factor individually. Previous venous thromboembolism is one of the stron- gest risk factors, even in patients actively treated with anticoagulant. Patients are more likely to have recur- rent venous thromboembolism with longer duration. Psoriasis is a complex immune–mediated disease, as- sociated with cardiovascular risk, hypercoagulability markers and elevated homocysteine. Lots of observati- onal reports suggest increased incidence of venous trombembolic events in patient with psoriasis